Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contaminant problems for heparin

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

    REFERENCE

    1. 1.

      Tuffs A.German manufacturer is told to withdraw heparin. BMJ 336: 635, No. 7645, 22 Mar 2008

    2. 2.

      Health Canada.B. Braun Recalls Contaminated Heparin Products in Canada. Media Release: 20 Mar 2008. Available from: URL: http://www.hc-sc.gc.ca

    3. 3.

      FDA.B. Braun's Supplier Recall of Heparin API Prompts Voluntary Recall of Heparin Solutions. Media Release: 21 Mar 2008. Available from: URL: http://www.fda.gov

    4. 4.

      FDA.Urgent safety advisory on use of Heparin products. Media Release: 20 Mar 2008. Available from: URL: http://www.tga.gov.au

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Contaminant problems for heparin. React. Wkly. 1196, 2 (2008). https://doi.org/10.2165/00128415-200811960-00002

    Download citation

    Keywords

    • Heparin
    • Adverse Reaction
    • Allergic Reaction
    • Medical Device
    • Dialysis Patient